Drugs / ASA

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01361763 Comparator Jun 2011 → Jan 2015 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 S. Andrea Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ASA “treatment with ASA one tablet of 100mg/day once a day for 12 weeks” NCT01361763